The global biotechnology reagents market size reached US$ 78,719 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 126,677 Million by 2028, exhibiting a growth rate (CAGR) of 8.50% during 2023-2028. More Info:- https://www.imarcgroup.com/biotechnology-reagents-market

1. Global Biotechnology
Reagents Market
Research and Forecast
Report 2023-2028
Format: PDF+EXCEL
© 2023 IMARC All Rights Reserved

2. About IMARC Group
International Market Analysis Research and Consulting Group is a leading adviser on management
strategy and market research worldwide. We partner with clients in all regions and industry
verticals to identify their highest-value opportunities, address their most critical challenges, and
transform their businesses.
IMARC’s information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods
are at the top of the company’s expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our clients
achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting
results.

3. Report Highlight
and Description
According to the latest report by IMARC Group, titled "Biotechnology
Reagents Market: Global Industry Trends, Share, Size, Growth,
Opportunity and Forecast 2023-2028," the global biotechnology reagents
market size reached US$ 78,719 Million in 2022.
Biotechnology reagents refer to essential substances utilized in diagnostic,
research, and experimental procedures within the biotechnology field. They
facilitate specific biological reactions that aid in detecting, quantifying, and
studying various biological entities and phenomena. Biotechnology reagents
are predominantly composed of organic compounds or biological substances,
such as enzymes, antibodies, and nucleic acids. They are classified into
deoxyribonucleic acid (DNA) sequencing, cell culture, polymerase chain
reaction (PCR), and immunoassay reagents.
Biotechnology reagents exhibit properties such as high specificity, stable
nature, and predictability in response. They are utilized in drug discovery and
development, forensic testing, disease research, and genomic studies.
Biotechnology reagents provide numerous benefits, including enhanced
experimental efficiency, increased reliability in results, and cost-effectiveness
when used at scale. Moreover, they save considerable research time, ensure
precision, yield consistent outcomes, adapt to diverse tests, support rapid
diagnostics, enhance reproducibility, and amplify sensitivity in assays.
Request for a PDF sample of this report:
https://www.imarcgroup.com/biotechnology -reagents-market/requestsample

4. Report Description
Global Biotechnology Reagents Market Trends:
The exponential growth in the biopharmaceutical sector is one of the major factors creating a positive outlook for
the market. In line with this, the widespread utilization of high-quality reagents that ensure precision in research
as companies strive to discover novel drugs and therapies is bolstering the market growth. Additionally, the
growing reliance on biotechnological processes owing to the escalating prevalence of diseases and the global
focus on personalized medicine is positively influencing the market growth. Besides this, the increasing allocation
of funds by academic and research institutions to biological research, leading to the consumption of reagents, is
propelling the market growth. In addition, the widespread product utilization in genomics and proteomics for
sequencing and protein analysis is anticipated to drive the market growth.
Apart from this, rapid advancements in high-throughput screening, allowing researchers to conduct millions of
biochemical, genetic, or pharmacological tests, are favoring the market growth. In addition to this, the rising
establishment of contract research organizations (CROs) that offer research services on behalf of another
organization, such as a pharmaceutical or biotechnological company, is acting as a growth-inducing factor.
Furthermore, the implementation of governmental initiatives, fostering a conducive environment for
biotechnological research, is providing remunerative growth opportunities for the market.
Looking forward, the market value is projected to reach US$ 126,677 Million by 2028, expanding at a CAGR
of 8.50% during 2023-2028.
View Report TOC, Figures and Tables: https://www.imarcgroup.com/biotechnology-reagents-market

5. Report
Segmentation
Technology Insights:
• Life Science Reagents
o PCR
o Cell Culture
o Hematology
o In-Vitro Diagnostics
o Others
• Analytical Reagents
o Chromatography
o Mass Spectrometry
o Electrophoresis
o Flow Cytometry
o Others
Application Insights:
• Protein Synthesis and Purification

6. Report
Segmentation
• Gene Expression
• DNA and RNA Analysis
• Drug Testing
• Others
Regional Insights:
• North America
• Asia-Pacific
• Europe
• Latin America
• Middle East and Africa

7. Competitive
Landscape with
Key Players
• Agilent Technologies Inc.
• Beckman Coulter Inc. (Danaher Corporation)
• Becton Dickinson and Company
• bioMérieux SA
• Bio-Rad Laboratories Inc.
• Illumina Inc.
• Lonza Group AG
• Merck KGaA
• Meridian Bioscience Inc. (SD Biosensor)
• PerkinElmer Inc.
• Promega Corporation
• Thermo Fisher Scientific Inc.
• Waters Corporation

8. Key Questions
Answered in
the Report
How has the global biotechnology reagents market performed
so far, and how will it perform in the coming years?
What are the drivers, restraints, and opportunities in the
global biotechnology reagents market?
What is the impact of each driver, restraint, and opportunity
on the global biotechnology reagents market?
What are the key regional markets?
Which countries represent the most attractive biotechnology
reagents market?
What is the breakup of the market based on technology?
Which is the most attractive technology in the biotechnology
reagents market?

9. Key Questions
Answered in
the Report
What is the breakup of the market based on the application?
Which is the most attractive application in the biotechnology
reagents market?
What is the competitive structure of the global biotechnology
reagents market?
Who are the key players/companies in the global
biotechnology reagents market?

10. Table of
Contents
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biotechnology Reagents Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Technology
6.1 Life Science Reagents
6.1.1 Mark et Trends
6.1.2 Key Segments
6.1.2.1 PCR
6.1.2.2 Cell Culture
6.1.2.3 Hematology
6.1.2.4 In-Vitro Diagnostics
6.1.2.5 Others
6.1.3 Mark et Forecast

11. Table of
Contents
6.2 Analytical Reagents
6.2.1 Mark et Trends
6.2.2 Key Segments
6.2.2.1 Chromatography
6.2.2.2 Mass Spectrometry
6.2.2.3 Electrophoresis
6.2.2.4 Flow Cytometry
6.2.2.5 Others
6.2.3 Mark et Forecast
7 Market Breakup by Application
7.1 Protein Synthesis and Purification
7.1.1 Mark et Trends
7.1.2 Mark et Forecast
7.2 Gene Expression
7.2.1 Mark et Trends
7.2.2 Mark et Forecast
7.3 DNA and RNA Analysis
7.3.1 Mark et Trends
7.3.2 Mark et Forecast
7.4 Drug T esting
7.4.1 Mark et Trends
7.4.2 Mark et Forecast
7.5 Others
7.5.1 Mark et Trends
7.5.2 Mark et Forecast
For more information, visit :
https://www.imarcgroup.com/biotechnology -reagents-
market/toc

12. Disclaimer
© 2023 IMARC All Rights Reserved
This Publication and all it’s contents unless otherwise mentioned are copyrighted in the
name of International Market Analysis Research and Consulting (IMARC). No part of this
publication may be reproduced, repackaged, redistributed or resold in whole or in any part.
The publication may also not be used in any form or by and means graphic electronic or
mechanical, including photocopying, recording, taping or by information storage or retrieval,
or by any other form, without the express consent of International Market Analysis Research
and Consulting (IMARC).
Disclaimer: All contents and data of this publication, including forecasts, data analysis and
opinion have been based on information and sources believed to be accurate and reliable at
the time of publishing. International Market Analysis Research and Consulting makes no
representation of warranty of any kind as to the accuracy or completeness of any Information
provided. IMARC accepts no liability whatsoever for any loss or damage resulting from
opinion, errors or inaccuracies if any found this publication.
IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of
International Market Analysis Research and Consulting. All other trademarks used in this
publication are registered trademarks of their respective companies.

13. Contact Us
Visit us at :
https://www.imarcgroup.com
TELEPHONE: +1-631-791-1145
E-MAIL: sales@imarcgroup.com